Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 30, 2025CureusOpen Access

Iatrogenic Botulism Following Unregulated Cosmetic Botulinum Toxin Injection

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAbdul Basit

Discussion

Loading...

Member takes

Overview

Case report details a patient with iatrogenic botulism after unregulated botulinum toxin injections, highlighting public health implications.

Key Points

  • Patient developed iatrogenic botulism symptoms after botulinum toxin injections, requiring intensive care and monitoring.
  • Injections were administered unlicensed by a non-medical acquaintance, indicating significant risks of cosmetic procedures.
  • Antitoxin therapy and multidisciplinary care assisted patient recovery, showcasing the need for prompt recognition and intervention.
  • Case underscores dangers of unregulated access to botulinum toxin and highlights public health responsibilities.

Cite This Study

Abdul Basit (2025) studied this question.

synapsesocial.com/papers/68dc262a8a7d58c25ebb372ehttps://doi.org/10.7759/cureus.93517
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Unlicensed Cosmetic Botulinum Injection Leading to Iatrogenic Botulism: A Case Analysis and Insights2025
  2. 2From Botox Party to Botulism: A Case Report and Public Health Warning on Adulterated Botulinum Toxin Injection2024 · 9 citations
  3. 3Iatrogenic botulism induced by cosmetic injection requiring mechanical ventilation: clinical characteristics and outcomes2026
  4. 4Case Report: Botulism associated with cosmetic BoNT-A injections: respiratory failure and multidrug-resistant infection as emerging clinical challenges2025 · 1 citations
  5. 5A102-18 A Critical Care Cascade: Iatrogenic Systemic Botulism Complicated by Biphasic Anaphylaxis and Airway Compromise2026